INS and breast cancer: For instance, experimental models show that modification of insulin levels associated with glycemic dysregulation appears early during cancer development: Pancreatic carcinogenesis (Li, 2012) and breast cancer are preceded by modifications of blood insulin levels (Ferroni et al., 2016).